Ionis gets approval for preventing attacks in rare and genetic HAE
In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as…
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
“Non-cystic fibrosis bronchiectasis deeply affects the lives of people living with this chronic lung condition, impacting both their…
Experts warn of the cancer-causing chemicals that are a ‘threat to humanity’
The human body contains more than 3,600 synthetic toxins, a new report has warned, with chemical exposure now…
What is kratom? All about the addictive supplement amid crackdown
It’s a green, mean, killing machine. At least according to Health and Human Services Secretary Robert F. Kennedy…
FDA denies approval for drug that improved a Rankin County teen’s life
RANKIN CO., Miss. (WLBT) – A Rankin County teenager’s life-changing medication is being denied approval by the U.S.…
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Teva Pharmaceutical Industries Ltd FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in…
It’s past time for the U.S. to embrace reciprocal drug approval
Domperidone is an important medication used primarily to treat nausea and to stimulate a sluggish gastrointestinal tract. Clinicians consider it…
FDA to add new warning labels to prescription opioid pain medications
The Food and Drug Administration has announced that every prescription for opioid pain medication will now have a…
FDA seeks to classify 7-OH as Schedule 1 drug amid addiction concerns
WASHINGTON (TNND) — The Trump administration is calling for the compound 7-OH, a popular by-product of the Kratom…
FDA panel weighs ban on fluoride tablets and drops for kids
The Food and Drug Administration (FDA) said it plans to ban fluoride tablets and drops, which have long…